PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1.90 - 2.15
0.48 - 2.54
9.88M / 2.92M (Avg.)
-0.48 | -4.19
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
111.14%
Revenue growth above 1.5x OGI.TO's 38.48%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
91.08%
Gross profit growth 1.25-1.5x OGI.TO's 68.94%. Bruce Berkowitz would see if strategic sourcing or brand premium explains outperformance.
10.33%
EBIT growth below 50% of OGI.TO's 240.14%. Michael Burry would suspect deeper competitive or cost structure issues.
10.33%
Operating income growth under 50% of OGI.TO's 240.14%. Michael Burry would be concerned about deeper cost or sales issues.
10.46%
Net income growth under 50% of OGI.TO's 127.47%. Michael Burry would suspect the firm is falling well behind a key competitor.
10.98%
EPS growth under 50% of OGI.TO's 126.49%. Michael Burry would suspect deeper structural issues or share dilution limiting per-share gains.
10.98%
Diluted EPS growth under 50% of OGI.TO's 126.49%. Michael Burry would worry about an eroding competitive position or excessive dilution.
-1.98%
Share reduction while OGI.TO is at 5.95%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
0.00%
Diluted share reduction more than 1.5x OGI.TO's 5.95%. David Dodd would validate if the company is aggressively retiring shares or limiting option exercises.
No Data
No Data available this quarter, please select a different quarter.
48.20%
Positive OCF growth while OGI.TO is negative. John Neff would see this as a clear operational advantage vs. the competitor.
11.57%
Positive FCF growth while OGI.TO is negative. John Neff would see a strong competitive edge in net cash generation.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-109.58%
Negative 10Y OCF/share CAGR while OGI.TO stands at 0.00%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
-109.58%
Negative 5Y OCF/share CAGR while OGI.TO is at 0.00%. Joel Greenblatt would question the firm’s operational model or cost structure.
-888.70%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
-9.81%
Negative 10Y net income/share CAGR while OGI.TO is at 0.00%. Joel Greenblatt sees a major red flag in long-term profit erosion.
-9.81%
Negative 5Y net income/share CAGR while OGI.TO is 0.00%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
-28.19%
Negative 3Y CAGR while OGI.TO is 113.87%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
19.21%
Equity/share CAGR of 19.21% while OGI.TO is zero. Bruce Berkowitz might see a slight advantage that can compound significantly over 10 years.
19.21%
Equity/share CAGR of 19.21% while OGI.TO is zero. Bruce Berkowitz might see a minor advantage that could compound if the firm maintains positive net worth growth.
135.88%
Below 50% of OGI.TO's 520.69%. Michael Burry suspects a serious short-term disadvantage in building book value.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
24.20%
AR growth well above OGI.TO's 12.00%. Michael Burry fears inflated revenue or higher default risk in the near future.
-2.65%
Inventory is declining while OGI.TO stands at 42.29%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
-1.88%
Negative asset growth while OGI.TO invests at 6.55%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
-0.13%
Both erode book value/share. Martin Whitman suspects a difficult environment or poor capital deployment for both players.
No Data
No Data available this quarter, please select a different quarter.
-37.31%
Our R&D shrinks while OGI.TO invests at 0.00%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
53.56%
SG&A growth well above OGI.TO's 18.71%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.